… of diabetes, cardiovascular complications are considered to contribute largely to the death
rate of diabetes because of diabetic cardiomyopathy (DCM), sudden cardiac death, and …

… non-ischemic heart failure associated with diabetes termed as diabetic cardiomyopathy (DCM…
Further, therapeutic modulation of miRs has gained some interest in diabetic heart disease …

… molecular and metabolic pathways underlying cardiac … , which may progress to heart
failure. It also highlights several … These tiny, noncoding RNA molecules play a critical role in …

… of tiny non-coding regulatory RNAs, are differentially expressed in the diabetic heart and they
contribute to diabetic cardiomyopathy… molecular mechanisms by which miRNA ameliorates …

… of noncoding, conserved, tiny (19–24 nt) … diabetes and cardiovascular diseases because
each miRNA has several targets that allows it to make a layer of regulatory network. Diabetes is …

… II (CaMKII) is upregulated in diabetes and significantly contributes to cardiac remodeling with
increased risk of cardiac arrhythmias. Diabetes is frequently associated with atrial fibrillation…

… per se, a cardiomyopathy that leads to heart failure [8]. Diabetic cardiomyopathy is the focus
of active basic and clinical medicine to understand the cellular and molecular basis of DM …

… , and GLUT-1 and -4 depletion contribute to myocyte injury at the molecular level (15). …
However, until the early stage of diabetes, heart damage remains tiny and discrete. As the …

… Diabetic Cardiomyopathy (DCM) is a macrovascular complication of DM that occurs in 12%
of DM patients. DCM is defined as a pathophysiological condition of the heart induced by …

… molecular aspects of diabetic cardiomyopathy have been introduced; in this section, studies
providing evidence for a role of epigenetics in the development of diabetic cardiomyopathy …